Correlation Between Compass Therapeutics and Inventiva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Compass Therapeutics and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compass Therapeutics and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Compass Therapeutics and Inventiva Sa, you can compare the effects of market volatilities on Compass Therapeutics and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compass Therapeutics with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compass Therapeutics and Inventiva.

Diversification Opportunities for Compass Therapeutics and Inventiva

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Compass and Inventiva is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Compass Therapeutics and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Compass Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compass Therapeutics are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Compass Therapeutics i.e., Compass Therapeutics and Inventiva go up and down completely randomly.

Pair Corralation between Compass Therapeutics and Inventiva

Given the investment horizon of 90 days Compass Therapeutics is expected to generate 1.04 times more return on investment than Inventiva. However, Compass Therapeutics is 1.04 times more volatile than Inventiva Sa. It trades about 0.04 of its potential returns per unit of risk. Inventiva Sa is currently generating about -0.01 per unit of risk. If you would invest  125.00  in Compass Therapeutics on August 29, 2024 and sell it today you would earn a total of  26.00  from holding Compass Therapeutics or generate 20.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Compass Therapeutics  vs.  Inventiva Sa

 Performance 
       Timeline  
Compass Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Compass Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Compass Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Inventiva Sa 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Inventiva Sa are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Inventiva sustained solid returns over the last few months and may actually be approaching a breakup point.

Compass Therapeutics and Inventiva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Compass Therapeutics and Inventiva

The main advantage of trading using opposite Compass Therapeutics and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compass Therapeutics position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.
The idea behind Compass Therapeutics and Inventiva Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements